Page 4 - Nasdaq Itrm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DUBLIN, Ireland and CHICAGO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical...

Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 2,720,000 shares, a drop of 34.9% from the April 30th total of 4,180,000 shares. Approximately 1.5% of the shares of the company are sold short. Based on an average daily […]

Iterum Therapeutics (NASDAQ:ITRM – Get Rating) issued its earnings results on Friday. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.03, Fidelity Earnings reports. Shares of ITRM opened at $0.22 on Monday. The firm has a market cap of $39.95 million, a P/E ratio of […]

Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 4,180,000 shares, an increase of 56.6% from the April 15th total of 2,670,000 shares. Approximately 2.3% of the company’s shares are short sold. Based […]

Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 3,550,000 shares, an increase of 27.2% from the March 15th total of 2,790,000 shares. Based on an average daily volume of 1,480,200 shares, the days-to-cover ratio is […]